Showing results (201-210 of 215) with videos related to

Sort By:
Pageof 22
Lancet (London, England)|December 20, 2017
Screening in the community to reduce fractures in older women (SCOOP): a randomised controlled trialLee Shepstone, Elizabeth Lenaghan, Cyrus Cooper, et al.
Pilot and Feasibility Studies|March 6, 2026
TaIlored ManagEment of Sleep (TIMES) for people with dementia and mild cognitive impairment in primary care in England: protocol for a feasibility cluster-randomised controlled trialJayden van Horik, Louise Allan, Aidin Aryankhesal, et al.
The New England Journal of Medicine|May 6, 2011
Leukotriene antagonists as first-line or add-on asthma-controller therapyDavid Price, Stanley D Musgrave, Lee Shepstone, et al.
Trials|May 31, 2020
Protocol for the process evaluation of a cluster randomised controlled trial to determine the effectiveness and cost-effectiveness of independent pharmacist prescribing in care home: the CHIPPS studyChristine M Bond, Richard Holland, David P Alldred, et al.
Trials|January 23, 2020
Protocol for a cluster randomised controlled trial to determine the effectiveness and cost-effectiveness of independent pharmacist prescribing in care homes: the CHIPPS studyChristine M Bond, Richard Holland, David P Alldred, et al.
BMJ Open|July 2, 2021
DECRYPT trial: study protocol for a phase II randomised controlled trial of cognitive therapy for post-traumatic stress disorder (PTSD) in youth exposed to multiple traumatic stressorsLeila Allen, Polly-Anna Ashford, Ella Beeson, et al.
BMJ Open|November 18, 2022
Understanding primary care diagnosis and management of sleep disturbance for people with dementia or mild cognitive impairment: a realist review protocolLeanne Greene, Aidin Aryankhesal, Molly Megson, et al.
Lancet (London, England)|October 24, 2021
Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trialSube Banerjee, Juliet High, Susan Stirling, et al.
International Psychogeriatrics|July 19, 2022
Cost-effectiveness of mirtazapine for agitated behaviors in dementia: findings from a randomized controlled trialCatherine Henderson, Martin Knapp, Susan Stirling, et al.
Health Technology Assessment (Winchester, England)|November 6, 2023
A pragmatic, multicentre, double-blind, placebo-controlled randomised trial to assess the safety, clinical and cost-effectiveness of mirtazapine and carbamazepine in people with Alzheimer's disease and agitated behaviours: the HTA-SYMBAD trialSube Banerjee, Nicolas Farina, Catherine Henderson, et al.
Pageof 22